A Pedrazzini

508 total citations
23 papers, 245 citations indexed

About

A Pedrazzini is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A Pedrazzini has authored 23 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Hematology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A Pedrazzini's work include Prostate Cancer Treatment and Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Bone health and treatments (4 papers). A Pedrazzini is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Bone health and treatments (4 papers). A Pedrazzini collaborates with scholars based in Switzerland, Italy and United States. A Pedrazzini's co-authors include Kurt Brunner, Aron Goldhirsch, T. Cerny, Enrico Roggero, R Joss, M. Castiglione, F. Cavalli, Bernadette Mermillod, R.D. Gelber and Rudolf Morant and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

A Pedrazzini

20 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Pedrazzini Switzerland 10 134 69 66 44 32 23 245
C.A.M. de Swart Netherlands 5 161 1.2× 55 0.8× 35 0.5× 50 1.1× 29 0.9× 8 430
Sreekanth Reddy United States 6 178 1.3× 96 1.4× 47 0.7× 72 1.6× 28 0.9× 11 289
N. Sakuragi Japan 11 81 0.6× 36 0.5× 27 0.4× 79 1.8× 32 1.0× 28 423
Gary Zeger United States 12 156 1.2× 151 2.2× 43 0.7× 61 1.4× 48 1.5× 19 315
Juan G. Posada Colombia 8 83 0.6× 24 0.3× 56 0.8× 51 1.2× 13 0.4× 22 244
Anne‐Chantal Braud France 6 115 0.9× 51 0.7× 46 0.7× 95 2.2× 158 4.9× 10 420
Desmond Robb Canada 7 141 1.1× 20 0.3× 43 0.7× 91 2.1× 36 1.1× 9 328
K Govind Babu India 9 124 0.9× 42 0.6× 32 0.5× 48 1.1× 63 2.0× 33 250
A Miliani Italy 6 140 1.0× 25 0.4× 195 3.0× 122 2.8× 21 0.7× 24 320

Countries citing papers authored by A Pedrazzini

Since Specialization
Citations

This map shows the geographic impact of A Pedrazzini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Pedrazzini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Pedrazzini more than expected).

Fields of papers citing papers by A Pedrazzini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Pedrazzini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Pedrazzini. The network helps show where A Pedrazzini may publish in the future.

Co-authorship network of co-authors of A Pedrazzini

This figure shows the co-authorship network connecting the top 25 collaborators of A Pedrazzini. A scholar is included among the top collaborators of A Pedrazzini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Pedrazzini. A Pedrazzini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gillessen, Silke, Giuseppe Procopio, Stefanie Hayoz, et al.. (2023). Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16). Journal of Clinical Oncology. 41(20). 3608–3615. 2 indexed citations
3.
Salzberg, Marc, Christoph Rochlitz, Rudolf Morant, et al.. (2007). An Open-Label, Noncomparative Phase II Trial to Evaluate the Efficacy and Safety of Docetaxel in Combination with Gefitinib in Patients with Hormone-Refractory Metastatic Prostate Cancer. Oncology Research and Treatment. 30(7). 355–360. 32 indexed citations
4.
Roggero, Enrico, et al.. (2005). Gefitinib (‘Iressa’, ZD1839) is active against brain metastases in a 77 year old patient. Journal of Neuro-Oncology. 71(3). 277–280. 11 indexed citations
5.
Marini, Giovanni, A Pedrazzini, Aron Goldhirsch, et al.. (1997). High-dose chemotherapy with autologous stem cell transplantation is feasible and safe in a regional hospital. A 6-year experience in southern Switzerland. Bone Marrow Transplantation. 19(1). 3–7. 3 indexed citations
6.
Wernli, Martin, André Tichelli, V von Fliedner, et al.. (1994). Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. British Journal of Haematology. 87(1). 39–43. 14 indexed citations
7.
Pedrazzini, A. (1993). Erythropoietin and GM-CSF following autologous bone marrow transplantation. European Journal of Cancer. 29. S15–S17. 5 indexed citations
8.
Pedrazzini, A. (1992). Current and Potential Applications for Erythropoietin. Acta Haematologica. 87(1). 2–3. 5 indexed citations
9.
Wilder‐Smith, Clive H., et al.. (1991). Ceftriaxone and Amikacin versus Ceftazidime and Amikacin in Febrile Granulocytopenia. Chemotherapy. 37(5). 346–352. 8 indexed citations
10.
Freedman, Arnold S., A Pedrazzini, & Lee M. Nadler. (1991). B-Cell Monoclonal Antibodies and Their Use in Clinical Oncology. Cancer Investigation. 9(1). 69–84. 3 indexed citations
11.
Pedrazzini, A, Arnold S. Freedman, & Lee M. Nadler. (1989). Autologous bone-marrow transplantation in Non-Hodgkin's lymphomas. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 989(1). 11–24. 6 indexed citations
12.
Pedrazzini, A, AS Freedman, Janet Andersen, et al.. (1989). Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function. Blood. 74(6). 2203–2211. 29 indexed citations
13.
Cerny, T., A Pedrazzini, R Joss, & Kurt Brunner. (1988). Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC). European Journal of Cancer and Clinical Oncology. 24(11). 1791–1794. 24 indexed citations
14.
Pedrazzini, A, F. Cavalli, Kurt Brunner, Aron Goldhirsch, & Bernadette Mermillod. (1987). Complete Remission following Endocrine or Combined Cytotoxic and Hormonal Treatment in Advanced Breast Cancer. Oncology. 44(1). 51–59. 14 indexed citations
15.
Pedrazzini, A, et al.. (1986). First repeated bone scan in the observation of patients with operable breast cancer.. Journal of Clinical Oncology. 4(3). 389–394. 26 indexed citations
16.
Powles, R, et al.. (1984). Mismatched family bone marrow transplantation.. PubMed. 21(3). 182–7. 25 indexed citations
17.
Cavalli, F., A Pedrazzini, G Martz, et al.. (1983). Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancer. European Journal of Cancer and Clinical Oncology. 19(11). 1615–1624. 16 indexed citations
18.
Pedrazzini, A & E Salvidio. (1957). Enzymveränderungen der Blutplättchen bei den hypoprothrombinämischen Morgagni-Laennec’schen Lebercirrhosen. Acta Haematologica. 18(1). 42–48. 6 indexed citations
19.
Pedrazzini, A & E Salvidio. (1956). [Enzymes of human thrombocytes and their probable importance in the mechanism of blood coagulation (hemostasis)].. PubMed. 86(38). 1097–8. 1 indexed citations
20.
Pedrazzini, A, et al.. (1954). [Pharmacodynamic and clinical studies with stypturon].. PubMed. 43(25). 552–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026